Exact Mass: 521.3253398
Exact Mass Matches: 521.3253398
Found 84 metabolites which its exact mass value is equals to given mass value 521.3253398
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Chenodeoxycholylglutamic acid
Chenodeoxycholylglutamic acid belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylglutamic acid consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Glutamic acid conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylglutamic acid, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylglutamic acid appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Deoxycholylglutamic acid
Deoxycholylglutamic acid belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholylglutamic acid consists of the bile acid deoxycholic acid conjugated to the amino acid Glutamic acid conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholylglutamic acid, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholylglutamic acid appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
2-[2-(17-Amino-5,13,14,16-tetrahydroxy-3,7-dimethylheptadecan-4-yl)oxy-2-oxoethyl]butanedioic acid
Ile Val Tyr Lys
C26H43N5O6 (521.3213178000001)
Ile Lys Val Tyr
C26H43N5O6 (521.3213178000001)
Ile Lys Tyr Val
C26H43N5O6 (521.3213178000001)
Ile Val Lys Tyr
C26H43N5O6 (521.3213178000001)
Ile Tyr Lys Val
C26H43N5O6 (521.3213178000001)
Ile Tyr Val Lys
C26H43N5O6 (521.3213178000001)
Lys Ile Val Tyr
C26H43N5O6 (521.3213178000001)
Lys Ile Tyr Val
C26H43N5O6 (521.3213178000001)
Lys Leu Val Tyr
C26H43N5O6 (521.3213178000001)
Lys Leu Tyr Val
C26H43N5O6 (521.3213178000001)
Lys Val Ile Tyr
C26H43N5O6 (521.3213178000001)
Lys Val Leu Tyr
C26H43N5O6 (521.3213178000001)
Lys Val Tyr Ile
C26H43N5O6 (521.3213178000001)
Lys Val Tyr Leu
C26H43N5O6 (521.3213178000001)
Lys Tyr Ile Val
C26H43N5O6 (521.3213178000001)
Lys Tyr Leu Val
C26H43N5O6 (521.3213178000001)
Lys Tyr Val Ile
C26H43N5O6 (521.3213178000001)
Lys Tyr Val Leu
C26H43N5O6 (521.3213178000001)
Leu Lys Val Tyr
C26H43N5O6 (521.3213178000001)
Leu Lys Tyr Val
C26H43N5O6 (521.3213178000001)
Leu Val Lys Tyr
C26H43N5O6 (521.3213178000001)
Leu Val Tyr Lys
C26H43N5O6 (521.3213178000001)
Leu Tyr Lys Val
C26H43N5O6 (521.3213178000001)
Leu Tyr Val Lys
C26H43N5O6 (521.3213178000001)
Val Ile Lys Tyr
C26H43N5O6 (521.3213178000001)
Val Ile Tyr Lys
C26H43N5O6 (521.3213178000001)
Val Lys Ile Tyr
C26H43N5O6 (521.3213178000001)
Val Lys Leu Tyr
C26H43N5O6 (521.3213178000001)
Val Lys Tyr Ile
C26H43N5O6 (521.3213178000001)
Val Lys Tyr Leu
C26H43N5O6 (521.3213178000001)
Val Leu Lys Tyr
C26H43N5O6 (521.3213178000001)
Val Leu Tyr Lys
C26H43N5O6 (521.3213178000001)
Val Tyr Ile Lys
C26H43N5O6 (521.3213178000001)
Val Tyr Lys Ile
C26H43N5O6 (521.3213178000001)
Val Tyr Lys Leu
C26H43N5O6 (521.3213178000001)
Val Tyr Leu Lys
C26H43N5O6 (521.3213178000001)
Tyr Ile Lys Val
C26H43N5O6 (521.3213178000001)
Tyr Ile Val Lys
C26H43N5O6 (521.3213178000001)
Tyr Lys Ile Val
C26H43N5O6 (521.3213178000001)
Tyr Lys Leu Val
C26H43N5O6 (521.3213178000001)
Tyr Lys Val Ile
C26H43N5O6 (521.3213178000001)
Tyr Lys Val Leu
C26H43N5O6 (521.3213178000001)
Tyr Leu Lys Val
C26H43N5O6 (521.3213178000001)
Tyr Leu Val Lys
C26H43N5O6 (521.3213178000001)
Tyr Val Ile Lys
C26H43N5O6 (521.3213178000001)
Tyr Val Lys Ile
C26H43N5O6 (521.3213178000001)
Tyr Val Lys Leu
C26H43N5O6 (521.3213178000001)
Tyr Val Leu Lys
C26H43N5O6 (521.3213178000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]undec-4-ene-1-sulfonic acid
(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid
4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
2-{2-[(17-amino-5,13,14,16-tetrahydroxy-3,7-dimethylheptadecan-4-yl)oxy]-2-oxoethyl}butanedioic acid
2-{[(1-{[(3z,9z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]amino}-3-methylpentanoic acid
C26H43N5O6 (521.3213178000001)
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13r,16s,17r,18s)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl (2r)-2-methylbutanoate
(11e,13e)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-15-(hydroxymethyl)-5,7,9-trimethyl-1-oxacyclohexadeca-3,11,13-triene-2,10-dione
2-[({1-[(2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl)-c-hydroxycarbonimidoyl]-2-methylbutyl}-c-hydroxycarbonimidoyl)amino]-3-methylpentanoic acid
C26H43N5O6 (521.3213178000001)